LEMBOREXANT TREATMENT FOR INSOMNIA IN PHASE 3: IMPACT ON DISEASE SEVERITY

Roth, T; Rosenberg, R; Murphy, P; Yardley, J; Kumar, D; Pinner, K; Perdomo, C; Moline, M

SLEEP, 2019; 42 ():